At ASPHALION, we are part of the IN2SIGHT consortium, an EU-funded project, and we are delighted to be currently participating in the 4th annual meeting at the 3Rs congress in Milano: “The role of 3Rs in the age of One Health: where we are and where we’re going”.
In2Sight aims at fostering an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials.
Our expert Marta Rayo Lunar is giving a talk about the REGULATORY ASPECTS OF 3Rs: “Paving the Way for New In Vivo Validation Alternatives”, where she will cover the main regulatory guidelines and regulatory bodies related to the 3Rs in medicinal development.
For any further information about In2Sight or EU-funded projects, you can contact us at: [email protected]
